Mobile and pervasive computing technologies and the future of Alzheimer’s clinical trials

The rapid growth of mobile phones, automated speech recognizing personal assistants, and internet access among the elderly provides new opportunities for incorporating such technologies into clinical research and personalized medical care. Alzheimer’s disease is a good test case given the need for early detection, the high rate of clinical trial failures, the need to more efficiently recruit patients for trials, and the need for sensitive and ecologically valid trial outcomes.

[1]  C. Lyketsos,et al.  A randomized trial of a web-based platform to help families manage dementia-related behavioral symptoms: The WeCareAdvisor™. , 2017, Contemporary clinical trials.

[2]  R. Sperling,et al.  Re-Engineering Alzheimer Clinical Trials: Global Alzheimer's Platform Network. , 2016, The journal of prevention of Alzheimer's disease.

[3]  Luís Macedo,et al.  It is not only memory: effects of sensecam on improving well-being in patients with mild alzheimer disease , 2017, International Psychogeriatrics.

[4]  R. Sperling,et al.  The Feasibility of At-Home iPad Cognitive Testing For Use in Clinical Trials. , 2016, The journal of prevention of Alzheimer's disease.

[5]  Hong Chen,et al.  Entosis Acts as a Novel Way within Sertoli Cells to Eliminate Spermatozoa in Seminiferous Tubule , 2017, Front. Physiol..

[6]  Denzil A. Harris,et al.  Novel methods and technologies for 21st-century clinical trials: a review. , 2015, JAMA neurology.

[7]  R. Sperling,et al.  The preclinical Alzheimer cognitive composite: measuring amyloid-related decline. , 2014, JAMA neurology.

[8]  Giuseppe Fico,et al.  A Succinct Overview of Virtual Reality Technology Use in Alzheimer’s Disease , 2015, Front. Aging Neurosci..

[9]  A. Vita,et al.  Feasibility and effectiveness of cognitive remediation in the treatment of borderline personality disorder , 2018, Neuropsychological rehabilitation.

[10]  Ipsit V Vahia,et al.  Mobile Health Technology in Late-Life Mental Illness: A Focused Literature Review. , 2017, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[11]  José Luis Molinuevo,et al.  Development of interventions for the secondary prevention of Alzheimer's dementia: the European Prevention of Alzheimer's Dementia (EPAD) project. , 2016, The lancet. Psychiatry.

[12]  Moriah E. Thomason,et al.  Enhancing Cognitive Abilities with Comprehensive Training: A Large, Online, Randomized, Active-Controlled Trial , 2015, PloS one.

[13]  Basel Kikhia,et al.  Utilizing a Wristband Sensor to Measure the Stress Level for People with Dementia , 2016, Sensors.

[14]  Anthony Almudevar,et al.  Home monitoring using wearable radio frequency transmitters , 2008, Artif. Intell. Medicine.

[15]  M. Carrillo,et al.  Everyday technologies for Alzheimer's disease care: Research findings, directions, and challenges , 2009, Alzheimer's & Dementia.

[16]  S. Giroux,et al.  Impact of AP@LZ in the daily life of three persons with Alzheimer’s disease: long-term use and further exploration of its effectiveness , 2018, Neuropsychological rehabilitation.

[17]  N. Bier,et al.  Can people with Alzheimer's disease improve their day-to-day functioning with a tablet computer? , 2018, Neuropsychological rehabilitation.

[18]  J. Cummings,et al.  Alzheimer's drug-development pipeline: 2016 , 2016, Alzheimer's & dementia.

[19]  E. Topol.  Digital medicine: empowering both patients and clinicians , 2016, The Lancet.

[20]  C. Mariani,et al.  Worldwide trends in the prevalence of dementia , 2017, Journal of the Neurological Sciences.

[21]  Adriana M. Seelye,et al.  Pervasive Computing Technologies to Continuously Assess Alzheimer’s Disease Progression and Intervention Efficacy , 2015, Front. Aging Neurosci..

[22]  J. Morris,et al.  The Alzheimer's Disease Neuroimaging Initiative 3: Continued innovation for clinical trial improvement , 2017, Alzheimer's & Dementia.

[23]  J. Honoré,et al.  Autonomic Reactivity to Arousing Stimuli with Social and Non-social Relevance in Alexithymia , 2017, Front. Psychol..

[24]  S. Friend,et al.  The mPower study, Parkinson disease mobile data collected using ResearchKit , 2016, Scientific Data.

[25]  Glyn W. Humphreys,et al.  'Who's that girl?' Prosopagnosia, person-based semantic disorder, and the reacquisition of face identification ability , 2002 .

[26]  Vaibhav A. Narayan,et al.  Beyond magic bullets: true innovation in health care , 2013, Nature Reviews Drug Discovery.

[27]  M. El Haj,et al.  Google Calendar Enhances Prospective Memory in Alzheimer's Disease: A Case Report. , 2017, Journal of Alzheimer's disease : JAD.

[28]  Déborah Alexandra Foloppe,et al.  Detecting Everyday Action Deficits in Alzheimer’s Disease Using a Nonimmersive Virtual Reality Kitchen , 2014, Journal of the International Neuropsychological Society.